Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1

被引：3

作者：

Wannigama, Dhammika Leshan ^{[1
,2
,3
,4
,6
,7
,8
]}

Amarasiri, Mohan ^{[2
,9
]}

Phattharapornjaroen, Phatthranit ^{[2
,10
,11
]}

Hurst, Cameron ^{[2
,12
]}

Modchang, Charin ^{[13
,14
,15
]}

Chadsuthi, Sudarat ^{[16
]}

Anupong, Suparinthon ^{[1
,13
]}

Miyanaga, Kazuhiko ^{[17
]}

Cui, Longzhu ^{[17
]}

Fernandez, Stefan ^{[18
]}

Huang, Angkana ^{[19
]}

Ounjai, Puey ^{[20
]}

Singer, Andrew C. ^{[21
]}

Ragupathi, Naveen Kumar Devanga ^{[4
,22
]}

Sano, Daisuke ^{[23
,24
]}

Furukawa, Takashi

Sei, Kazunari ^{[8
]}

Leelahavanichkul, Asada ^{[2
,25
]}

Kanjanabuch, Talerngsak ^{[5
,26
,27
,28
]}

Chatsuwan, Tanittha ^{[4
,8
]}

Higgins, Paul G. ^{[2
,29
,30
,31
]}

Nanbo, Asuka ^{[32
]}

Kicic, Anthony

Siow, Richard ^{[37
,38
,39
]}

Trowsdale, Sam ^{[40
]}

Hongsing, Parichart ^{[41
]}

Khatib, Aisha ^{[33
,34
,35
,36
,42
]}

Shibuya, Kenji ^{[43
]}

Abe, Shuichi ^{[2
]}

Ishikawa, Hitoshi ^{[2
,8
]}

机构：

[1] Yamagata Prefectural Cent Hosp, Dept Infect Dis & Infect Control, Yamagata 9902292, Japan

[2] Yamagata Prefectural Cent Hosp, Dept Infect Dis & Infect Control, Pathogen Hunters Res Collaborat Team, Yamagata, Japan

[3] Yamagata Prefectural Univ Hlth Sci, Yamagata, Japan

[4] Chulalongkorn Univ, Fac Med, Ctr Excellence Antimicrobial Resistance & Stewards, Bangkok, Thailand

[5] Chulalongkorn Univ, Ctr Excellence Kidney Metab Disorders, Fac Med, Bangkok, Thailand

[6] Univ Western Australia, Fac Hlth & Med Sci, Sch Med, Perth, WA, Australia

[7] Univ Sheffield, Biofilms & Antimicrobial Resistance Consortium ODA, Sheffield, England

[8] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Microbiol,Fac Med, Bangkok, Thailand

[9] Kitasato Univ, Sch Allied Hlth Sci, Grad Sch Med Sci, Dept Hlth Sci,Lab Environm Hyg, Tokyo, Japan

[10] Mahidol Univ, Fac Med, Ramathibodi Hosp, Bangkok, Thailand

[11] Gothenburg Univ, Dept Surg, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden

[12] Charles Darwin Univ, Molly Wardaguga Res Ctr, Brisbane, Qld, Australia

[13] Mahidol Univ, Fac Sci, Dept Phys, Biophys Grp, Bangkok, Thailand

[14] Minist Higher Educ Sci Res & Innovat, Ctr Excellence Phys, Bangkok, Thailand

[15] Minist Higher Educ, Ctr Excellence Math Sci Res & Innovat, Bangkok, Thailand

[16] Naresuan Univ, Fac Sci, Dept Phys, Phitsanulok, Thailand

[17] Jichi Med Univ, Div Bacteriol, Sch Med, Shimotsuke, Tochigi, Japan

[18] Armed Forces Res Inst Med Sci, Dept Virol, US Army Med Directorate, Bangkok, Thailand

[19] Univ Cambridge, Dept Psychol, Cambridge, England

[20] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand

[21] UK Ctr Ecol & Hydrol, Wallingford, England

[22] Bioberrys Healthcare & Res Ctr, Dept Res & Dev, Div Microbial Interact, Vellore, India

[23] Tohoku Univ, Grad Sch Environm Studies, Dept Frontier Sci Adv Environm, Sendai, Miyagi, Japan

[24] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Sendai, Miyagi, Japan

[25] Chulalongkorn Univ, Dept Microbiol, Translat Res Inflammat & Immunol Res Unit, Bangkok, Thailand

[26] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand

[27] Chulalongkorn Univ, Fac Med, Sch Global Hlth, Dialysis Policy & Practice Program, Bangkok, Thailand

[28] King Chulalongkorn Mem Hosp, Peritoneal Dialysis Excellence Ctr, Bangkok, Thailand

[29] Univ Cologne, Univ Hosp Cologne, Fac Med, Ctr Mol Med Cologne, Cologne, Germany

[30] Univ Cologne, Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Fac Med, Cologne, Germany

[31] German Ctr Infect Res, Cologne, Germany

[32] Nagasaki Univ, Natl Res Ctr Control & Prevent Infect Dis, Nagasaki, Japan

[33] Univ Western Australia, Telethon Kids Inst, Wal Yan Resp Res Ctr, Perth, WA, Australia

[34] Univ Western Australia, Ctr Cell Therapy & Regenerat Med, Med Sch, Perth, WA, Australia

[35] Perth Childrens Hosp, Dept Resp & Sleep Med, Perth, WA, Australia

[36] Curtin Univ, Sch Populat Hlth, Perth, WA, Australia

[37] Kings Coll London, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, Kings British Heart Fdn Ctr Res Excellence, London, England

[38] Kings Coll London, Ageing Res, London, England

[39] Univ Oxford, Dept Physiol Anat & Genet, Med Sci Div, Oxford, England

[40] Univ Auckland, Sch Environm, Auckland, New Zealand

[41] Mae Fah Luang Univ Hosp, Chiang Rai, Thailand

[42] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada

[43] Tokyo Fdn Policy Res, Tokyo, Japan

来源：

LANCET INFECTIOUS DISEASES | 2024年 / 24卷 / 06期

关键词：

D O I：

10.1016/S1473-3099(24)00155-5

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：e348 / e350

页数：3

共 50 条

[1] SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences
Wang, Xinling
Lu, Lu
Jiang, Shibo
[J]. TRENDS IN IMMUNOLOGY, 2024, 45 (02) : 81 - 84
[2] Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023
Jeworowski, Lara M.
Muehlemann, Barbara
Walper, Felix
Schmidt, Marie L.
Jansen, Jenny
Krumbholz, Andi
Simon-Loriere, Etienne
Jones, Terry C.
Corman, Victor M.
Drosten, Christian
[J]. EUROSURVEILLANCE, 2024, 29 (02)
[3] Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
Miah Roney
Mohd Fadhlizil Fasihi Mohd Aluwi
[J]. Bulletin of the National Research Centre, 48 (1)
[4] Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants
Haonan Yang
Huimin Guo
Aojie Wang
Liwei Cao
Qing Fan
Jie Jiang
Miao Wang
Lin Lin
Xiangyang Ge
Haiyan Wang
Runze Zhang
Ming Liao
Renhong Yan
Bin Ju
Zheng Zhang
[J]. Nature Communications, 15 (1)
[5] Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
Yang, Sijie
Yu, Yuanling
Xu, Yanli
Jian, Fanchong
Song, Weiliang
Yisimayi, Ayijiang
Wang, Peng
Wang, Jing
Liu, Jingyi
Yu, Lingling
Niu, Xiao
Wang, Yao
Shao, Fei
Jin, Ronghua
Cao, Youchun
[J]. LANCET INFECTIOUS DISEASES, 2024, 24 (02): : e70 - e72
[6] Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Planas, Delphine
Staropoli, Isabelle
Michel, Vincent
Lemoine, Frederic
Donati, Flora
Prot, Matthieu
Porrot, Francoise
Guivel-Benhassine, Florence
Jeyarajah, Banujaa
Brisebarre, Angela
Dehan, Oceane
Avon, Lea
Bolland, William Henry
Hubert, Mathieu
Buchrieser, Julian
Vanhoucke, Thibault
Rosenbaum, Pierre
Veyer, David
Pere, Helene
Lina, Bruno
Trouillet-Assant, Sophie
Hocqueloux, Laurent
Prazuck, Thierry
Simon-Loriere, Etienne
Schwartz, Olivier
[J]. NATURE COMMUNICATIONS, 2024, 15 (01)
[7] Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in South and Southeast Asia
Wannigama, Dhammika Leshan
Amarasiri, Mohan
Phattharapornjaroen, Phatthranit
Hurst, Cameron
Modchang, Charin
Chadsuthi, Sudarat
Anupong, Suparinthon
Miyanaga, Kazuhiko
Cui, Longzhu
Werawatte, W. K. C. P.
Rad, S. M. Ali Hosseini
Fernandez, Stefan
Huang, Angkana T.
Vatanaprasan, Porames
Saethang, Thammakorn
Luk-in, Sirirat
Storer, Robin James
Ounjai, Puey
Tacharoenmuang, Ratana
Ragupathi, Naveen Kumar Devanga
Kanthawee, Phitsanuruk
Cynthia, Bernadina
Besa, John Jefferson, V
Leelahavanichkul, Asada
Kanjanabuch, Talerngsak
Higgins, Paul G.
Nanbo, Asuka
Kicic, Anthony
Singer, Andrew C.
Chatsuwan, Tanittha
Trowsdale, Sam
Furukawa, Takashi
Sei, Kazunari
Sano, Daisuke
Ishikawa, Hitoshi
Shibuya, Kenji
Khatib, Aisha
Abe, Shuichi
Hongsing, Parichart
[J]. JOURNAL OF TRAVEL MEDICINE, 2024, 31 (04)
[8] Predicting antibody and ACE2 affinity for SARS-CoV-2 BA.2.86 and JN.1 with in silico protein modeling and docking
Yasa, Shirish
Guirales-Medrano, Sayal
Machado, Denis Jacob
Ford, Colby T.
Janies, Daniel
[J]. FRONTIERS IN VIROLOGY, 2024, 4
[9] Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1
Tong, Zhou
Tong, Jianyu
Lei, Wenwen
Xie, Yufeng
Cui, Yingzi
Jia, Guowen
Li, Shihua
Zhang, Zezhong
Cheng, Zhimin
Xing, Xiao
Ma, Haiyun
Deng, Lan
Zhang, Rong
Zhao, Xin
Liu, Kefang
Wang, Qihui
Qi, Jianxun
Huang, Haomin
Song, Rui
Su, Zhaoming
Wu, Guizhen
Lou, Jing
Gao, George Fu
[J]. CELL REPORTS, 2024, 43 (06):
[10] Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1
Sohail, Muhammad Saqib
Ahmed, Syed Faraz
Quadeer, Ahmed Abdul
Mckay, Matthew R.
[J]. VIRUSES-BASEL, 2024, 16 (03):

← 1 2 3 4 5 →